haloperidol has been researched along with Mouth Diseases in 7 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Mouth Diseases: Diseases involving the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This phenomenon, probably due to the inhibition of the striato-nigral GABA-ergic pathway, could serve as an easy and reliable model for the human tardive dyskinesias dues to the chronic administration of neuroleptics." | 1.28 | [Oral dyskinesia in rats after a single administration of haloperidol combined with GABA-linoleamide. A model of dyskinesia in man]. ( Vamvakides, A, 1989) |
| "Rats with ablated frontal sensorimotor cortex and one with ablated sensorimotor connections to forebrain showed more vacuous chewing movements following 6-week chronic administration of a neuroleptic than did occipitally damaged rats or normal controls who were treated in the same way." | 1.26 | Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. ( Glassman, HN; Glassman, RB, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glassman, RB | 1 |
| Glassman, HN | 1 |
| Gunne, LM | 2 |
| Häggström, JE | 1 |
| Growdon, JH | 1 |
| Parry, TJ | 1 |
| Eberle-Wang, K | 1 |
| Lucki, I | 1 |
| Chesselet, MF | 1 |
| Damodaran, SS | 1 |
| Thankamma, JK | 1 |
| Vamvakides, A | 1 |
| Dawn, G | 1 |
| Smith, G | 1 |
| Forsyth, A | 1 |
7 other studies available for haloperidol and Mouth Diseases
| Article | Year |
|---|---|
Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Chlorpromazine; Di | 1980 |
Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.
Topics: Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Glutamate Decarboxylase; Haloperido | 1983 |
A model for oral dyskinesia in rats.
Topics: Animals; Cerebral Cortex; Dyskinesia, Drug-Induced; Female; Haloperidol; Mastication; Mouth Diseases | 1982 |
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats.
Topics: Animals; Apomorphine; Benzazepines; Dopamine Agents; Dyskinesia, Drug-Induced; Haloperidol; Kainic A | 1994 |
Reversal of rabbit syndrome with olanzapine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Female; Haloperidol; Humans; M | 2000 |
[Oral dyskinesia in rats after a single administration of haloperidol combined with GABA-linoleamide. A model of dyskinesia in man].
Topics: Animals; Catalepsy; Disease Models, Animal; Drug Synergism; Dyskinesia, Drug-Induced; gamma-Aminobut | 1989 |
Dental veneers fitting: a cause for reactions to epoxy resin and BIS-GMA.
Topics: Adult; Dental Veneers; Dermatitis, Allergic Contact; Epoxy Resins; Female; Humans; Mouth Diseases | 2003 |